Depression

COVID-19 Depressed
Striking Rise in Depression and Anxiety During First 9 Months of Pandemic in US
Reports of anxiety and depression rose to a significant 50% and 44%, respectively, among US residents during the first 9 months of the COVID-19 pandemic, according to study results published online in Translational Behavioral Medicine.
Maternal Depression and Anxiety Increased Worldwide During Pandemic
Maternal symptoms of depression and anxiety were among a number of maternal and fetal outcomes that worsened globally during the COVID-19 pandemic, according to a systematic review and meta-analysis.
History of Depression May Increase Perception of Pandemic-Related Community Stress
A history of depression may increase one’s perception of the amount of stress caused by the COVID-19 pandemic in their community, according to a study presented in a poster session at the ADAA 2021 Virtual Conference.
Childhood Maltreatment May Predict Better Response to IV Ketamine
Confirming results from a previous smaller study, researchers found people who reported a history of childhood maltreatment had a more robust response to intravenous (IV) ketamine than other depressed adults seeking ketamine treatment.
Smartphone Keystroke Data May Unobtrusively Predict Mood Variability
Passive unobtrusive smartphone metadata could be used to prospectively predict elevations in mood disorder and depression symptoms, according to studies presented at the American Association for Geriatric Psychiatry 2021 Annual Meeting.
Psychedelics Bring Patients Face-to-Face with Underlying Issues
The use of psychedelics in psychotherapy can help patients go beyond ameliorating symptoms and confront their root causes of depression, Andrew D. Penn, RN, MS, NP, CNS, APRN-BC, and Charles Raison, MD, said at a session at the Psych Congress 2020…
Adjunctive Brexpiprazole Enhances Calming, Engagement in MDD
Patients with major depressive disorder (MDD) reported feeling calmer and more engaged after treatment with adjunctive brexpiprazole, according to a poster presented at Psych Congress 2020.
Daily Social Media Use Does Not Raise Depression Risk in Teens
Daily social media use is neither a strong nor consistent risk factor for depressive symptoms in adolescents in the United States, according to a new study published in the Journal of Adolescent Health.
Combining Ketamine With Psychotherapy to Treat Depression
A session being presented at Psych Congress 2020 will educate attendees on the practice of combining ketamine treatment with psychotherapy for patients with treatment-resistant depression (TRD).
Dr. Michael Thase Answers Your Questions on Depression Treatments
Michael E. Thase, MD, spoke at the 2020 Psych Congress Elevate conference on adjunctive and combination therapies for difficult-to-treat depression. Here, he answers some of the questions asked by attendees.
Join a Presentation by Dr. Charles Raison on Depression and the Pandemic
Psych Congress cochair Charles Raison, MD, will give a virtual keynote speech August 20, 2020, for the University of Louisville Depression Center’s annual benefit. The event is free and open to the public.

Videos

Dr. Robin Carhart-Harris on the Power of Psychedelics
Robin Carhart-Harris, PhD, head of the Centre of Psychedelic Research at Imperial College London in England, discusses the power of psychedelics.
Michael Thase, MD
Using Antipsychotics as an Adjunctive Therapy in Depression
Detecting Mixed Features in Major Depression
Best Practices for Administering Esketamine

Audio

A Discussion on Heat as a Novel Treatment for Depression
Psych Congress Steering Committee member Charles Raison, MD, discusses heat, including sauna use, as a novel treatment for depression and a tool for improving mental health.
Dr. Rakesh Jain Gives an Update on Glutamate
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, speaks with general psychiatrist Abbey Strauss, MD, MSW, about the history, chemistry, and potential use of the neurotransmitter…
Back to Top